Biomemory launches DNA Shield for synthetic-DNA data storage
Biomemory’s DNA Shield puts critical organisational data into offline synthetic DNA, with early access aimed at long-term sovereign data protection.
Biomemory has launched DNA Shield, a managed service that stores a small amount of an organisation’s most important information in synthetic DNA, kept offline and separated from the systems that use it. The Paris- and Boston-based company says its Early Access Programme is now open to organisations looking for a long-term, independent layer for critical digital assets.1
The service is aimed at material such as cryptographic keys, regulated records, proprietary industrial knowledge and institutional archives. Customers select and encrypt the information during onboarding; Biomemory then encodes it into synthetic DNA held under managed custody. Recovery is a controlled process rather than routine, self-service access, according to the company.1
What DNA Shield is for
DNA Shield is not being pitched as a replacement for ordinary servers, SSDs or cloud storage. Biomemory describes it as a separate preservation layer for information that must remain trustworthy over years or decades. The company says the DNA is stored offline, outside the network-reachable attack surface, and designed to remain recoverable despite cyberattacks, infrastructure changes and organisational turnover.1
The launch follows Biomemory’s acquisition of assets from Boston DNA-storage pioneer Catalog Technologies in March and the appointment of Laurent Guengant as chief executive earlier this year. Biomemory says the move has expanded its intellectual-property base and established production and research operations in Boston alongside its Paris headquarters.1
Early access is currently limited to a small number of pilots, with the company’s launch material describing DNA Shield as the first step in a broader Molecular IT roadmap. Biomemory says future stages will cover wider DNA storage, molecular search and computation, but those remain future plans rather than features of the service announced here.1
TechRadar reports that subscriptions are expected to start at €10,000 per month, with pilot availability running from October 15, 2026, into the middle of 2027.2 That price and the deliberately narrow use case make clear that DNA Shield is aimed at institutions protecting irreplaceable information, not consumers looking for a replacement hard drive.
Our opinion
DNA Shield is interesting because it treats DNA storage as an operational service instead of a laboratory demonstration. The practical question is not whether DNA can hold an astonishing amount of information, but whether a customer can trust the entire chain: encryption, encoding, custody, recovery and verification years later. Biomemory’s launch addresses that chain more directly than a typical research announcement, but the early-access stage means those claims still need to be tested by real deployments. For now, DNA Shield looks less like a new general-purpose storage format and more like an expensive, offline safety deposit box for data that organisations cannot afford to lose.